Blankenstein SA, Rohaan MW, Klop WMC, van der Hiel B, et al. Neoadjuvant Cytoreductive Treatment with BRAF/MEK Inhibition of prior Unresectable Regionally Advanced Melanoma to Allow Complete Surgical Resection, REDUCTOR: A Prospective, Single Arm, Open-label Phase II Trial. Ann Surg 2021 Apr 9. pii: 00000658-900000000-93605.
PMID: 33843797